Found: 61
Select item for more details and to access through your institution.
Continuous Glucose Monitoring to Diagnose Hypoglycemia Due to Late Dumping Syndrome in Children After Gastric Surgeries.
- Published in:
- Journal of the Endocrine Society, 2021, v. 5, n. 3, p. 1, doi. 10.1210/jendso/bvaa197
- By:
- Publication type:
- Article
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 583, p. 1, doi. 10.1126/scitranslmed.abc8980
- By:
- Publication type:
- Article
The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials.
- Published in:
- Diabetes Care, 2024, v. 47, n. 6, p. 1048, doi. 10.2337/dc24-0171
- By:
- Publication type:
- Article
Hydroxychloroquine in Stage 1 Type 1 Diabetes.
- Published in:
- Diabetes Care, 2023, v. 46, n. 11, p. 2035, doi. 10.2337/dc23-1096
- By:
- Publication type:
- Article
Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function.
- Published in:
- Diabetes Care, 2023, v. 46, n. 10, p. 1848, doi. 10.2337/dc23-0675
- By:
- Publication type:
- Article
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial.
- Published in:
- Diabetes Care, 2023, v. 46, n. 5, p. 1005, doi. 10.2337/dc22-2200
- By:
- Publication type:
- Article
The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2020, v. 43, n. 1, p. 5, doi. 10.2337/dc19-0880
- By:
- Publication type:
- Article
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA<sub>1c</sub> in New-Onset Type 1 Diabetes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Excess BMI in Childhood: A Modifiable Risk Factor for Type 1 Diabetes Development?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Two- and Four-Hour Tests Differ in Capture of C-Peptide Responses to a Mixed Meal in Type 1 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- letter
Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A cross-sectional study of osteocalcin and body fat measures among obese adolescents.
- Published in:
- Obesity (19307381), 2013, v. 21, n. 4, p. 808, doi. 10.1002/oby.20131
- By:
- Publication type:
- Article
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 746, p. 1, doi. 10.1126/scitranslmed.adn2404
- By:
- Publication type:
- Article
Congenital Hyperinsulinism in an Infant Caused by a Macroscopic Insulin-Producing Lesion.
- Published in:
- Journal of Pediatric Endocrinology & Metabolism, 2007, v. 20, n. 3, p. 437, doi. 10.1515/jpem.2007.20.3.437
- By:
- Publication type:
- Article
Prevalence and Characteristics of Type 2 Diabetes Mellitus in 9-18 Year-old Children with Diabetic Ketoacidosis.
- Published in:
- Journal of Pediatric Endocrinology & Metabolism, 2005, v. 18, n. 9, p. 865, doi. 10.1515/jpem.2005.18.9.865
- By:
- Publication type:
- Article
The Use of a Continuous Glucose Monitoring System in Hypoglycemic Disorders.
- Published in:
- Journal of Pediatric Endocrinology & Metabolism, 2004, v. 17, n. 3, p. 281, doi. 10.1515/jpem.2004.17.3.281
- By:
- Publication type:
- Article
Delayed growth and sexual development in a 15-year-old: A rose by any other name.
- Published in:
- Contemporary Pediatrics, 2000, v. 17, n. 12, p. 25
- By:
- Publication type:
- Article
Exenatide extended release in patients with type 1 diabetes with and without residual insulin production.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2045, doi. 10.1111/dom.14121
- By:
- Publication type:
- Article
Case Study: If the Numbers Don't Fit... Discrepancies Between Glucose Meter Readings and Hemoglobin A<sub>1c</sub> Reveal Stress of Living With Diabetes.
- Published in:
- Clinical Diabetes, 2006, v. 24, n. 1, p. 45, doi. 10.2337/diaclin.24.1.45
- By:
- Publication type:
- Article
Case Study: Type 1 and Type 2, Too?
- Published in:
- Clinical Diabetes, 2003, v. 21, n. 3, p. 140, doi. 10.2337/diaclin.21.3.140
- By:
- Publication type:
- Article
Comparison of autoantibody-positive and autoantibody-negative pediatric participants enrolled in the T1D Exchange clinic registry (在1型糖尿病交流中心临床登记的自身抗体阳性与自身抗体阴性的儿科参与者的比较)
- Published in:
- Journal of Diabetes, 2013, v. 5, n. 2, p. 216, doi. 10.1111/1753-0407.12031
- By:
- Publication type:
- Article
β-Cell Glucose Sensitivity to Assess Changes in β-Cell Function in Recent-Onset Stage 3 Type 1 Diabetes.
- Published in:
- Diabetes, 2023, v. 72, n. 9, p. 1289, doi. 10.2337/db23-0196
- By:
- Publication type:
- Article
1117-P: Characterizing Glucose/C-Peptide Response Curve (GCRC) Phenotypes to Enhance Selection Specificity for Type 1 Diabetes (T1D) Prevention Trials.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1117-P
- By:
- Publication type:
- Article
Low-Dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report.
- Published in:
- Diabetes, 2021, v. 70, n. 5, p. 1123, doi. 10.2337/db20-1103
- By:
- Publication type:
- Article
1689-P: Assessments of Alternative C-Peptide (C-P) Endpoints for New-Onset Type 1 Diabetes (T1D) Clinical Trials.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1689-P
- By:
- Publication type:
- Article
164-OR: Efficacy of New-Onset Type 1 Diabetes (T1D) Intervention Trials: Variation in 1-Year Outcomes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-164-OR
- By:
- Publication type:
- Article
95-OR: Interleukin-17 Receptor C Is a Regulator of Autoimmune Diabetes in Humans.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-95-OR
- By:
- Publication type:
- Article
85-OR: Modifiers of C-Peptide Change during the Progression to Type 1 Diabetes (T1D) in the TrialNet Pathway to Prevention Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-85-OR
- By:
- Publication type:
- Article
253-LB: Effect of Combined Low Dose IL-2 plus Polyclonal Tregs in Type 1 Diabetes Patients.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-253-LB
- By:
- Publication type:
- Article
187-LB: Glucose Response Curve (GRC) Shapes in Mixed Meal Tolerance Tests (MMTTs) and Prediction of Response to Intervention in the TrialNet New-Onset Clinical Trials.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-187-LB
- By:
- Publication type:
- Article
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA<sub>1c</sub>, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Role of Imatinib in Pediatric Type 1 Diabetes.
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 5, p. 1, doi. 10.1210/jcemcr/luae065
- By:
- Publication type:
- Article
A promoter within intron 35 of the human C4A gene initiates abundant adrenal-specific transcription of a 1 kb RNA: location of a cryptic CYP21 promoter element?
- Published in:
- Human Molecular Genetics, 1995, v. 4, n. 11, p. 2109
- By:
- Publication type:
- Article
Type 1 diabetes immunotherapy using polyclonal regulatory T cells.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 315, p. 1, doi. 10.1126/scitranslmed.aad4134
- By:
- Publication type:
- Article
Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
- Published in:
- 2009
- By:
- Publication type:
- commentary
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Real-Time Continuous Glucose Monitoring in Adolescents and Young Adults With Type 2 Diabetes Can Improve Quality of Life.
- Published in:
- Journal of Diabetes Science & Technology, 2024, v. 18, n. 4, p. 911, doi. 10.1177/19322968221139873
- By:
- Publication type:
- Article
Recommendations for the Definition of Clinical Responder in Insulin Preservation Studies.
- Published in:
- Diabetes, 2014, v. 63, n. 9, p. 3120, doi. 10.2337/db14-0095
- By:
- Publication type:
- Article
Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial.
- Published in:
- Diabetes, 2013, v. 62, n. 11, p. 3766, doi. 10.2337/db13-0345
- By:
- Publication type:
- Article
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Fall in C-Peptide During First 2 Years From Diagnosis.
- Published in:
- Diabetes, 2012, v. 61, n. 8, p. 2066, doi. 10.2337/db11-1538
- By:
- Publication type:
- Article
Analysis of T-Cell Assays to Measure Autoimmune Responses in Subjects With Type 1 Diabetes.
- Published in:
- Diabetes, 2006, v. 55, n. 9, p. 2588, doi. 10.2337/db05-1378
- By:
- Publication type:
- Article
A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes.
- Published in:
- 2005
- By:
- Publication type:
- journal article